Zausner Meryl 4
4 · Seres Therapeutics, Inc. · Filed Sep 4, 2018
Insider Transaction Report
Form 4
Zausner Meryl
Director
Transactions
- Award
Stock Option (right to buy)
2018-08-30+30,000→ 30,000 totalExercise: $8.47Exp: 2028-08-29→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest in four equal installments on each anniversary of 08/30/2018 or in full immediately prior to the occurrence of a change in control.